Timing of Therapies

Our predecessor site BCCT summarizes the evidence regarding the effects of timing of therapies with cancer.

.

Statins

Our predecessor site BCCT summarizes the evidence regarding statins’ effects with cancer.

.

Rapamycin (Sirolimus)

By blocking certain functions of the mTOR enzyme, rapamycin reduces cell growth. It therefore may be useful in treating or preventing proliferative diseases, including cancer.

.

Propranolol and Other Beta Blockers

Our predecessor site BCCT summarizes the evidence regarding propranolol’s and other beta blockers’ effects with cancer.

.

Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce inflammation, with notable benefits in increasing survival and reducing risk of several types of cancer; expert consensus is that the risks of harm from using these drugs long-term for prevention are greater than the benefits for many people.

.

Metformin

Metformin, used to manage diabetes, shows some benefits in lower risks of cancer and better survival, mostly among people with diabetes or high blood sugar.

.

Low-dose Naltrexone

This prescription drug is used off-label in low doses to treat people with cancer, with notable but very preliminary successes in cases where the cancers were difficult-to-treat or quite advanced.

.

Hyperthermia

Many types and varieties of hyperthermia (heat treatment) are used in conventional cancer care, and some additional uses are being explored for improving survival and reducing risk of recurrence.

.

Copper Chelation

Copper promotes the formation of blood vessels, including those that supply tumors. Depleting copper can deprive the tumor of its suppliers.

.

Cimetidine and Other H2 Blockers

H2 blockers, used to treat gastrointestinal ulcers and/or reduce stomach acid, may improve survival among people with cancer, especially after colorectal cancer resection.

.
Next page